The initial public offering (IPO) of Star Health and Allied Insurance, which ended yesterday, saw a subscription rate of 79%, according to the data available on the BSE.
The government has said that there is no proposal as of now to merge public-sector general insurance companies.
With the number and the severity of natural calamities rising by the year, a new report published by the State Bank of India (SBI) has called for creating a national disaster pool for India.
Entering the retirement phase and reaping its various benefits is something that everyone looks forward to experiencing. However, without adequate savings or a strong retirement corpus, enjoying your golden years can be a tad bit hard. Financial preparedness and a thorough understanding of one's requirements are crucial aspects to evaluate during retirement. Here's a quick guide to planning your retirement, ensuring you avoid any financial instabilities during your 'second innings'.
There is a need for urgent strategies to mitigate financial toxicity among patients with cancer in India, especially in the most deprived sections of society, according to the findings of a systematic review of the issue.
A committee has submitted its report to the International Financial Services Centres Authority (IFSCA) proposing several key areas and recommendations to develop the IFSC as a global hub for insurance and reinsurance activities.
In its endeavour to give back to society, ICICI Lombard General Insurance will offer support for the treatment of underprivileged individuals suffering from critical illness.
Star Health and Allied Insurance Company has set a price band of INR870 ($11.66) to INR900 a share for its initial public offering. At the upper end of the price band, the IPO is expected to fetch INR72.49bn ($970m).
Niva Bupa Health Insurance has announced its mid-term growth target, projecting a gross written premium of INR50m ($672m) by the financial year ending 31 March 2024 (FY2024).
Indian life insurers have reported strong value of new business (VNB) growth in the second quarter of 2022, on the back of high annual premium equivalent (APE), on a low base and expansion in margins due to higher operating leverage and a favourable product mix.